Navigation Links
UConn scientist develops sterile variety of invasive plant
Date:8/16/2011

re grown.

"Finding the right combination of plant growth regulators, appropriate amounts for the treatment and repeatedly testing and re-testing the process to validate success was a lengthy, yet ultimately rewarding, process," Li says.

The process to produce triploid plants from endosperm tissues is so difficult that since endosperm regeneration of plants was first reported in the early 1950's, it has been successful in only 32 plant species. Li praised his research team's persistence, dedication and passion, which he said carried his staff through the long hours necessary for separating thousands of mature and immature endosperms once the plants went to seed in the fall.

The research report appears in the August 2011 issue of HortScience, an international journal serving horticulture scientists and the horticulture industry.

The research team reports that it successfully produced twelve independently regenerated triploid plants of burning bush. Triploid plants are sterile due to uneven chromosome division as cells multiply. Li is working with UConn's Office of Technology Commercialization to patent the process used to regenerate the burning bush triploid and ultimately bring the new plant variety to the commercial horticulture industry.


'/>"/>

Contact: Colin Poitras
colin.poitras@uconn.edu
860-486-4656
University of Connecticut
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UConn cardiologists uncover new heart attack warning sign
2. UConn chemists find secret to increasing luminescence efficiency of carbon nanotubes
3. Gladstone scientists offer new insight into the regulation of stem cells and cancer cells
4. UCLA life scientists study of abalone yields new insights into sexual reproduction
5. Scientists highlight link between stress and appetite
6. Scientists link shifting Atlantic mackerel distribution to environmental factors, changing climate
7. Scientists identify mutation in SIGMAR1 gene linked to juvenile ALS
8. Carnegie Mellon scientists discover how molecular motors go into energy save mode
9. In quest for new therapies, clinician-scientist team unlocks hidden information in human genome
10. Scientists copy the ways viruses deliver genes
11. Scientists explore the role of aeroecology in bat conservation and ecosystem health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... NYU Langone Medical Center,s Departments of Orthopaedic Surgery and ... to detect subtle changes in joint cartilage microstructure ... markers of early osteoarthritis (OA). By using these techniques ... shift the management of the disease from eventual joint ...
... The last century has seen two major pandemics caused ... and 2009,s Swine Flu scare, which had thousands travelling with ... know what distinguished the Swine Flu from ordinary influenza in ... to travel extensively and infect large populations. Until now. ...
... MO, August 15, 2011A compound found in green tea ... treat two types of tumors and a deadly congenital ... led by Principal Investigator, Dr. Thomas Smith at The ... The Children,s Hospital of Philadelphia. Their findings are published ...
Cached Biology News:NYU Langone experts find MRI techniques can detect early osteoarthritis 2Could the Spanish flu devastate us again? 2Researchers demonstrate green tea is effective in treating genetic disorder and types of tumors 2
(Date:5/5/2015)... , May 05, 2015 Research ... has announced the addition of the ... to their offering. Macromolecules which ... undergo separation or are broken into smaller ... products. This separation requires various advanced systems ...
(Date:5/5/2015)... DIEGO , May 5, 2015  Renova™ ... for congestive heart failure and other chronic diseases, ... an independent analysis designed to reflect the healthcare ... time. This model will be used to characterize ... CHF, could have on those groups of patients ...
(Date:5/5/2015)... D.C., USA (PRWEB) May 05, 2015 ... regulations covering a wide range of key photonics technologies ... hampering global competitiveness of U.S. industry. To help the ... webinar on 12 May on the proposed changes ... the commodities covered by International Traffic in Arms Regulations ...
(Date:5/5/2015)... FRANCISCO, Calif. , May 5, 2015 ... treatment of cancer, today announced that Sean McCarthy ... the Credit Suisse Antibody Day in New ... May 6. Dr. McCarthy will present an overview of ... and Probody drug conjugate programs. About CytomX ...
Breaking Biology Technology:Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... 8 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... and live webcast at 9:00 a.m. Eastern Time on ... financial results.,Michael T. Flavin, Ph.D., Chairman & Chief Executive ... present an update on the Company.,A press release reporting ...
... Calif., Nov. 7 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group Corporation ... nine months of 2007 were $6,214,712,an increase of 567% ... Revenues for the third quarter of 2007 were ... third quarter of 2006. These significant,increases are due to ...
... at 1:30 p.m. (Pacific); ... http://www.adventrx.com , SAN DIEGO, Nov. 7 ... and development company,focused on commercializing proprietary product candidates for ... results for,the three-month and nine-month periods ended September 30, ...
Cached Biology Technology:Advanced Life Sciences to Host Third Quarter 2007 Financial Results Conference Call and Live Webcast 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 3Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 4Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 5Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 6Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 7Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 8Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 9ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 2ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 3ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 4ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 5ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 6ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 7
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Mouse monoclonal [b/e4 (9.20)] to Cytochrome P450 2B1 + 2B2 ( Abpromise for all tested applications)....
Goat polyclonal to MLH3 Immunogen: Synthetic peptide: RQSLQQSMPPCEPP (Human) from C Terminus of the protein sequence according to NP_055196....
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biology Products: